SWMG
PFE icon

Stillwater Wealth Management Group’s Pfizer PFE Stock Holding History

Stillwater Wealth Management Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$658K Buy
23,430
+9,395
+67% +$250K 0.41% 50
2025
Q4 		$349K Buy
14,035
+810
+6% +$20.4K 0.24% 59
2025
Q3 		$337K Buy
+13,225
New +$326K 0.24% 58

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Stillwater Wealth Management Group's PFE Position: Q1 2026 in Review

Stillwater Wealth Management Group increased its Pfizer (PFE) stake by 67% in Q1 2026, buying an estimated $250K and bringing the position to 23,430 shares worth $658K. The position accounts for 0.41% of the portfolio, ranked #50.

Stillwater Wealth Management Group first reported a position in PFE in Q3 2025 and has held it in 3 quarters since. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Stillwater Wealth Management Group held 23,430 shares of Pfizer worth $658K as of Q1 2026.
  • Stillwater Wealth Management Group bought 9,395 Pfizer shares in Q1 2026, an estimated $250K.
  • Pfizer made up 0.41% of Stillwater Wealth Management Group's portfolio in Q1 2026, its #50 holding.
  • Stillwater Wealth Management Group first reported a position in Pfizer in Q3 2025 and has held it in 3 quarters since.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Stillwater Wealth Management Group's 13F filing for Q1 2026, filed 11 May 2026.